Consensus Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
132.9 ^USD	+0.17%		+13.29%	+33.63%

May. 17	Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing	MT
May. 17	Sector Update: Health Care Stocks Mixed Late Afternoon	MT

Evolution of the average Target Price on Moderna, Inc.

Price target over the last 5 years

History of analyst recommendation changes

03acdabe0091b7944b.0c7SPNmhJhS2tsI_VaktTuJBaXW-WRvUs_-Ya8bRIvk.ppmdDa7EdlXY2I9ZA-dXIoAWBCf_YCPk0cjvAaSySZGdtOBwtfJ3TfHEpQ~633740effe27d01907b80a7d19088ef4

Analyst Recommendations on Moderna, Inc.

Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing	May. 17	MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	May. 17	MT
ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor...	May. 14
Evercore ISI Initiates Moderna With In Line Rating, $120 Price Target	May. 14	MT
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing	May. 13	MT
Deutsche Bank Raises Moderna's Price Target to $85 From $70	May. 09	MT
UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating	May. 07	MT
News Highlights : Top Financial Services News of the Day - Monday at 11 AM ET	May. 06	DJ
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing	May. 06	MT
Jefferies Adjusts Price Target on Moderna to $155 From $125	May. 03	MT
Oppenheimer Adjusts Price Target on Moderna to $163 From $142	May. 03	MT
Goldman Sachs Adjusts Price Target on Moderna to $204 From $206	May. 03	MT
Leerink Adjusts Price Target on Moderna to $60 From $59	May. 03	MT
Morgan Stanley Adjusts Price Target on Moderna to $95 From $89	May. 03	MT
Jefferies & Co Adjusts Moderna Price Target to $155 From $125	May. 03	MT
Goldman Sachs Adjusts Moderna Price Target to $204 From $206	May. 03	MT
Morgan Stanley Raises Price Target on Moderna to $95 From $89, Keeps Equalweight Rating	May. 03	MT
RBC Raises Price Target on Moderna to $135 From $125 on 'More Prudent Financial Outlook,' Keeps Outperform Rating	May. 03	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
MODERNA : price target raised by Oddo BHF	May. 03	CF
RBC Raises Price Target on Moderna to $135 From $125	May. 02	MT
Chardan Research Lowers Metagenomi's PT to $17 From $21 on Heels of Announced Termination of Collaboration With Moderna, Keeps Buy Rating	May. 02	MT
Moderna Secures Contract to Supply 12.5 Million COVID-19 Vaccine Doses to Brazil	Apr. 22	MT
Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing	Apr. 16	MT
Redburn Adjusts Moderna's Price Target to $117 From $110	Apr. 12	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

132.9 USD

Average target price

138.5 USD

Spread / Average Target

+4.22%

High Price Target

310 USD

Spread / Highest target

+133.26%

Low Price Target

60 USD

Spread / Lowest Target

-54.85%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Moderna, Inc.

Evercore ISI
Deutsche Bank Securities
UBS
Jefferies & Co.
Oppenheimer
Goldman Sachs
Leerink Partners
Morgan Stanley
RBC Capital Markets
Redburn
HSBC
Canaccord Genuity
RBC	Luca Issi
JPMorgan Chase
Argus
TD Cowen
William Blair & Co.
Guggenheim
SVB Securities LLC
Cowen
Chardan Research
Piper Sandler
SVB Leerink
BofA Securities
Wolfe Research
Barclays
Chardan
J.P. Morgan Chase

Ratings for Moderna, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar